Time to Vaccination After Rituximab (RTX) Discontinuation in Patients with anti–Aquaporin–4 Antibody–Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): A Post-Hoc Analysis of the CHAMPION-NMOSD Trial (P11-8.011)
Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available
10.1212/wnl.0000000000208553